Zevra Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	27.46	10.16	28.65	13.29	12.84	0	0	0	0	0	Upgrade
Revenue Growth (YoY)	170.26%	-64.53%	115.61%	3.50%	-	-	-	-	-	-	Upgrade
Cost of Revenue	2.95	0.22	2.06	0	0	0	0	0	0	0	Upgrade
Gross Profit	24.52	9.94	26.59	13.29	12.84	0	0	0	0	0	Upgrade
Selling, General & Admin	34.31	15.04	8.7	7.92	10.82	12.51	12.77	14	8.88	4.53	Upgrade
Research & Development	39.81	19.8	10.16	8.84	19.42	41.76	20.59	20.47	13.93	11.92	Upgrade
Other Operating Expenses	0	17.66	0	2.13	2.95	1.64	0	3.01	0	0	Upgrade
Operating Expenses	74.12	52.5	18.86	18.9	33.18	55.9	33.37	37.48	22.81	16.44	Upgrade
Operating Income	-49.6	-42.57	7.73	-5.61	-20.34	-55.9	-33.37	-37.48	-22.81	-16.44	Upgrade
Interest Expense / Income	1.5	0.34	0.23	4.79	4.86	5.47	5.78	5.51	2.67	1.61	Upgrade
Other Expense / Income	-5.06	-16.1	16.02	2.4	-0.65	-4.78	4.29	-26.46	29.15	6.43	Upgrade
Pretax Income	-46.05	-26.81	-8.52	-12.79	-24.54	-56.59	-43.43	-16.53	-54.64	-24.48	Upgrade
Income Tax	0	-0.03	0.03	-0.03	-0.02	-0.13	-0.04	-0.02	0.03	-0.02	Upgrade
Net Income	-46.05	-26.77	-8.56	-12.76	-24.52	-56.47	-43.39	-16.52	-54.66	-24.46	Upgrade
Preferred Dividends	0	0	54.34	0	0	0	0	0	0	0	Upgrade
Net Income Common	-46.05	-26.77	-62.9	-12.76	-24.52	-56.47	-43.39	-16.52	-54.66	-24.46	Upgrade
Shares Outstanding (Basic)	35	34	30	4	2	1	1	1	0	0	Upgrade
Shares Outstanding (Diluted)	35	34	30	4	2	1	1	1	0	0	Upgrade
Shares Change	2.79%	15.87%	647.71%	114.79%	65.39%	22.36%	0.38%	98.10%	209.47%	-	Upgrade
EPS (Basic)	-1.30	-0.78	-2.11	-3.21	-13.23	-50.39	-47.36	-18.08	-118.72	-164.32	Upgrade
EPS (Diluted)	-1.30	-0.78	-2.11	-3.21	-13.23	-50.39	-47.36	-18.08	-118.72	-164.32	Upgrade
Free Cash Flow	-33.83	-18.81	10.34	-1.97	-23.76	-54.22	-33.28	-30.42	-20.4	-14.72	Upgrade
Free Cash Flow Per Share	-0.95	-0.55	0.35	-0.49	-12.82	-48.39	-36.34	-33.34	-44.30	-98.90	Upgrade
Gross Margin	89.28%	97.82%	92.81%	100.00%	100.00%	-	-	-	-	-	Upgrade
Operating Margin	-180.63%	-418.91%	26.98%	-42.21%	-158.40%	-	-	-	-	-	Upgrade
Profit Margin	-167.69%	-263.48%	-219.54%	-96.03%	-191.00%	-	-	-	-	-	Upgrade
Free Cash Flow Margin	-123.20%	-185.12%	36.08%	-14.84%	-185.08%	-	-	-	-	-	Upgrade
EBITDA	-43.54	-25.53	-8.04	-7.74	-19.38	-50.8	-37.32	-10.85	-51.88	-22.8	Upgrade
EBITDA Margin	-158.56%	-251.22%	-28.06%	-58.22%	-150.96%	-	-	-	-	-	Upgrade
Depreciation & Amortization	1.01	0.94	0.26	0.27	0.3	0.32	0.34	0.18	0.08	0.08	Upgrade
EBIT	-44.55	-26.47	-8.3	-8.01	-19.69	-51.12	-37.65	-11.02	-51.97	-22.87	Upgrade
EBIT Margin	-162.22%	-260.51%	-28.95%	-60.27%	-153.33%	-	-	-	-	-	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).